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INTRODUCTION 
 
 Acute lower respiratory tract infections are one of the most important 
causes of childhood morbidity and mortality in developing countries. Bronchiolitis 
and pneumonia are the most common causes of acute lower respiratory tract 
infections in young children(1).  Acute lower respiratory tract infections in 
children are caused due to  bacterial  infection or viral infection(2). Common 
causes of viral LRIs are RSV and parainfluenza viruses. They usually present as 
Bronchiolitis.  
Pneumonias can be caused by both bacteria and viruses. Some of the 
causes of bacterial pneumonia are Streptococcus pneumonia (pneumococcus), 
Haemophilus influenzae, mostly type b (Hib), Staphylococcus aureus and group A 
Streptococci.  Mycoplasma pneumonia and Chlamydia pneumonia cause atypical 
pneumonias.(1) 
In developing countries prevalence of acute respiratory tract infections has 
been reported as 21.7 to 40%. It is estimated that 300 million episodes of ARI 
occur in India every year; of these 30 to 60 millions are moderate to severe ARI. 
While every 6th child in the world is Indian, every 4th child who dies, comes from 
India(3). 
In India, under-5 children constitute 13% of the total population and 25% 
to the mortality. Mortality statistics in India shows that ARIs cause 20%–35% of 
the mortality among under-5 children(4). The incidence of lower respiratory tract 
infection is 0.25–0.5 episodes /child/year(4). Various studies showed that among 
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the ARI events in children, 87% to 90% are due to upper respiratory infections, 
and 10%–13% are due to acute lower respiratory tract infections.  
 
Further, lower respiratory tract infections contribute 96.5% of mortality 
due to respiratory events. Studies showed that 33% of paediatric outpatients and 
admissions are due to acute respiratory events of which more than 90% 
admissions are due to lower respiratory tract infections(4). 
 
According to WHO global distribution of cause - specific mortality in 
children less than 5 years in 2004 is as follows(5). 
• Acute respiratory infections, mainly pneumonia (19%)  
• Diarrhoeal diseases (17%)  
• Other neonatal causes (27%)  
• Neonatal infections such as sepsis (10%) 
• Malaria (8%).  
• Measles (4%) 
• Others (15%) 
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Preventive measures for respiratory illnesses:
1. Avoidance of in utero and environmental tobacco smoke exposure
2. Prevention of low birth weight infants and prematurity
3. Promotion of breast 
4. Improvement in the living environment
5. Early treatment of respiratory infections
6. Promotion of improved nutrition
7. Timely immunizations particularly influenza vaccination
8. Improved parenting
Normal zinc status according to international reference value
serum zinc levels between 60
 
3 
8
4
17
10
27
Malaria 8%
Measles 4%
Diarrhoea 17%
Neonatal  infections10%
Other neonatal causes27%
ALRI (pneumonia)17%
Others
(1) 
 
feeding 
 
 
 
 
 
 µg/dl to 120µg/dl.(6)   
Under five mortality causes 
 
s is defined as 
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Zinc is a catalytic metal ion present in the cytoplasm of  cells of the body.   
Zinc is present in all cells, although about 80% is present in muscles and bone 
alone. It is present both in plasma and red cells of blood. One third of zinc in 
circulating plasma is bound to macroglobulin and to albumin.  
 Zinc is a key micronutrient required for intestinal mucosal integrity, 
skeletal growth and immune function predominantly cellular immunity and 
antioxidant activity. It is present in all organs, tissues and body fluids(7). 
Seminal fluid has higher concentration of zinc. Zinc is a constituent of 
numerous enzymes such as carbonic anhydrase, carboxyl peptidase, alkaline 
phosphatase, DNA and RNA polymerase, reverse transcriptase and superoxide 
dismutase. 
It has a lot of physiological functions. It is necessary for DNA replication 
and cell division. It has a role in maintaining cell integrity and immunity, and 
plays a key role in cells that have a rapid turnover. Therefore it plays a critical role 
in the control and prevention of infections.  
Despite these functions, the body does not store zinc. There are no readily 
mobilizable stores of zinc like iron and requires a constant dietary intake. Sources 
of zinc are red meat, animal proteins, seafood, dairy products, cereals and nuts. 
Most vegetables are not good sources of zinc due to the presence of phytate that 
chelates zinc and prevents its absorption(7).      
Although zinc’s role in diarrhoea is known, zinc supplementation during 
diarrhoea is recommended based on several trials demonstrating the effect of zinc 
in reducing the duration, severity and recurrence of diarrhoea(8). 
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There are some studies showing zinc deficiency as a risk factor for acute 
lower respiratory tract infections and supplementation of zinc as a preventive 
measure in reducing the incidence of acute lower respiratory tract infections(9). 
Trials with zinc supplementation in  pneumonia (tachypnea plus one or 
more of retractions, bronchial breathing, crackles, nasal flaring, danger signs) 
showed  
 reduced incidence of acute lower respiratory tract infections. Trials have also 
shown that there is no therapeutic benefit of adding zinc to antibiotic therapy(10). 
 
The balance of evidence suggests that(10) 
1. Zinc supplementation for at least three months duration could be useful to 
prevent pneumonia defined by specific criteria. 
2. Zinc does not have therapeutic value in childhood pneumonia. 
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REVIEW OF LITERATURE 
 
Zinc is a trace mineral which means the body requires very small amounts 
(<100mg/day) to function properly(11). Other trace minerals include iron, 
manganese, copper, fluoride, molybdenum, iodine, chromium and selenium. Zinc 
is an important micronutrient present in all organs, tissues, body fluids and body 
secretions. After iron, zinc is the second most abundant trace element in the body. 
 
The human body contains 2-3g of zinc(12). It ranges from 1.5g in women 
to 2.5g in men. Lean body mass concentration of zinc is 30µg/gram. It is 
distributed chiefly in skeletal muscles (60%) and bones (30%).  High 
concentrations of zinc are found in the choroid of the eye (274µg/g) and in 
prostatic fluids (300-500mg/l).(13) 
 
 Other organs containing significant concentrations of zinc include liver, 
intestines, kidney, pancreas, lung, brain, heart and skin. Plasma zinc accounts for 
0.1% of total body zinc, where it predominately exists in the bound form to 
several proteins like albumin, transferrin  and α-macroglobulin. 
 
Functions of zinc: 
Zinc is essential for a wide variety of physiological functions. It is required 
for the metabolic activity of 300 of the body`s enzymes and is a component of 
metalloproteinase important for DNA replication and cell division, crucial for 
cellular immunity and antioxidant activity. These enzymes are involved with the 
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metabolism of carbohydrate, protein, fat and alcohol. Zinc is part of several 
enzyme systems such as carbonic anhydrase. Zinc influences cell division, DNA 
metabolism, RNA metabolism, growth, development, sexual maturation and 
normal functioning of the immune system. . Zinc is essential for the synthesis and 
action of insulin. Zinc plays a key role in protein and nucleic acid synthesis(14). 
 
  Zinc is required for the maintenance of   normal skin and   intestinal 
mucosal integrity, skeletal growth, sodium and water transport. 
 
 It is required for normal leukocyte function and cytokine expression(15). 
Zinc is also crucial to tissue growth, wound healing, prostaglandin production, 
bone mineralization, proper thyroid function, blood clotting, foetal growth and 
sperm production.  
 
Zinc helps to enhance memory and improve mental functions and is 
especially critical for foetal brain development. Zinc is considered to play a key 
role in cells that have a rapid turnover and plays a crucial role in the control and 
prevention of infections. 
 
Zinc deficiency is now recognized as an important health issue particularly 
in developing countries making it a part of the “top micronutrients to consider in 
interventions” list joining iron, vitamin A, folic acid and iodine. 
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Daily requirements: 
 
 
 
 
 
        
 
  
  
 
The daily requirement of zinc for an adult male is 11mg, 8mg for women, 
12mg for pregnant and lactating women, 2mg for infants, 3mg for children 
between 1-3years and 5mg for children between 4-8years(14).   
 
Sources of zinc: 
Zinc is more abundant in lean red meat, beef, lamb and pork. Seafood such 
as shellfish, whole wheat, nuts, legumes, whole grain cereals such as bran and 
germ and dairy products like cheese and eggs are also good sources of zinc. 
Vegetables are not a good source of zinc due to the presence of phytate that 
chelates zinc and prevents its absorption(13). 
 
 
 
Adult   male  11 mg 
Adult female 8 mg 
Pregnancy  and lactation 12 mg 
Infants  2 mg 
1 to  3  years 3 mg 
4  to 8 years 5mg 
Daily requirement of Zinc 
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Zinc absorption and bioavailability: 
  The absorption of zinc in the gut probably occurs throughout the small 
intestine. Zinc absorption is highest in the jejunum. Several zinc transporters and 
binding proteins have been identified in the intestinal epithelial cells. The 
absorbed zinc is bound to albumin and then transported to the liver 
 
Bioavailability of zinc: 
People who depend on plant- based diets face the risk of zinc deficiency 
due to interference of phytate with zinc absorption. Phytate is present in plant 
foods such as fruits, leaves and vegetables and in whole grain cereals, legumes, 
nuts and seeds. 
 
 Phytate affects zinc absorption from the gastrointestinal tract through 
precipitation. As phytate cannot be digested or absorbed, zinc bound to phytate 
will pass through the intestines unabsorbed. 
 
Milling of cereals removes bran which has high content of phytate. 
Fermentation of cereals hydrolyses phytate and results in more zinc becoming 
bioavailable. Increase in protein increases zinc absorption.  
 WHO categories diets into three categories based on the phytate/zinc 
molar ratio as(16) 
1. Low  zinc bio available with phytate/zinc molar ratio more than 15  
2. Moderate zinc bio available with phytate/zinc molar ratio  less than 10  
and  
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3. High zinc bio available with phytate/zinc molar less than 5 
 
Zinc absorption increases with the protein content of a meal. The 
absorption is higher from a diet rich in animal protein (beef, poultry, cheese, eggs) 
than from a diet rich in plant proteins (soy, legumes). Other protein sources such 
as milk protein (casein) have an inhibitory effect on zinc absorption. 
 
Nutrient interactions with zinc:(11) 
1. Copper: High zinc decreases copper absorption leading to leucopoenia, 
neutropenia and lowers HDL. 
2. Iron: High zinc decreases iron absorption and vice versa, can lead to 
anaemia. 
3. Calcium: Calcium along with phytic acid decreases zinc absorption. 
4. Folic acid: Folate bioavailability may go up when zinc is present. 
5. Protein: Protein deficiency can cause zinc deficiency. 
 
Transport and storage of zinc: 
Zinc is absorbed in the small intestine and binds to metallothionein, a 
storage protein. Metallothionein binds zinc to albumin and helps in transport to 
tissues, mostly muscle and bone. Excess zinc is sloughed off along with dead cells 
and excreted by the pancreas into the intestinal tract and leaves the body via the 
faeces and to a lesser extent in urine and sweat(11). 
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Zinc deficiency: 
Severe zinc deficiency is defined as a condition characterized by short 
stature, hypogonadism, impaired immunity, skin diseases, cognitive dysfunction 
and anorexia(14). It is estimated that about one third of the world’s population has 
zinc deficiency ranging from    4% to 73%. Although severe zinc deficiency is 
rare, mild to moderate zinc deficiency is quite common. 
  
Symptoms of zinc deficiency: 
Deficiency of zinc can lead to anorexia, loss of appetite, depression, loss 
of smell and taste sensation, hair loss, diminished wound healing and impaired 
immune system increasing the susceptibility to infections. In pregnant women,  
lack of zinc may lead to low birth weight babies and affect foetal brain 
development(11). 
Deficiency of zinc in children will hinder their normal growth and 
development, and can lead to poor appetite, mental lethargy, short stature, 
diarrhoea, pneumonia and delayed sexual development.  
Zinc deficient adult males may develop prostatic hyperplasia. Zinc 
deficiency can also lead  to decreased sperm production and affect fertility(14). 
Zinc deficiency can cause ocular problems such as myopia, cataracts, 
delayed dark adaptation and macular degeneration. Despite these important 
functions of zinc, it is not stored in the body. Therefore a constant dietary intake 
of zinc is essential. 
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Risk groups for Zinc deficiency:(19) 
1. Rapid cell growth (Infants and children) 
2. Insufficient intake 
3. High phytate/ or fibre  in food 
4. Diarrhoea 
5. Malabsorption 
6. Parasitosis 
7. Hot humid climate 
8. Lactation 
9. Genetic disease (acrodermatitis enteropathica, sickle cell  anaemia) 
10. Parenteral nutrition. 
 
Mechanisms of zinc deficiency: 
1. Inadequate intake 
2. Increased requirement 
3. Malabsorption 
4. Increased losses 
5. Impaired utilization 
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Acute lower respiratory tract infections: 
Bronchiolitis and pneumonias including lobar pneumonia constitute majority 
of acute lower respiratory tract infections in children. 
 
Bronchiolitis: 
Acute Bronchiolitis is predominantly a viral disease.  More than 50% are due 
to RSV. Other causes are para influenza, adenovirus and mycoplasma, human 
metavirus and human bocavirus. Bronchiolitis is more common in males, who 
have not been breast fed and who live in crowded places. Bronchiolitis is 
usually seen in less than 2 years(5). 
Many factors like host, immunological and anatomical factors play a major 
role in the severity of the illness. Acute bronchiolitis is characterized by 
bronchiolar obstruction with edema, mucus and cellular debris. Hypoxemia is 
due to ventilation perfusion mismatch.  Severe obstruction and respiratory 
fatigue can lead to  hypercapnea. Bronchiolitis commonly presents with 
respiratory distress, tachypnea, wheeze or crepitations in infants and is usually 
preceded by upper respiratory illness.  
 
Pneumonia: 
Viral infections are a prominent cause of lower respiratory tract infections 
in children less than 5 years. Causes of pneumonia are RSV, other respiratory 
viruses,  pneumococcus,  H. Influenza, Mycoplasma pneumonia, group A 
streptococcus, etc. 
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The lower respiratory tract is normal sterile by physiological defence 
mechanism including mucociliary clearance, secretary IgA, macrophages and 
cough that clears the secretions. These immunological mechanisms prevent the 
pathogens invading the respiratory tract(5). 
 
Children with pneumonia present with fever, cough, increased work  of  
breathing (intercostal retractions,  suprasternal retractions, nasal flaring) or 
tachypnea. In severe pneumonia child presents with grunting, central cyanosis, 
inability to feed, lethargy, unconsciousness or head nodding. 
 
There is also evidence that the number of hospitalisations for acute lower 
respiratory tract infections is a risk factor for later respiratory morbidity and 
bronchiectasis. Therefore an intervention that reduces severity and frequency of 
acute lower respiratory tract infections would be useful(17). 
 
There are many risk factors including demographic, socioeconomic, 
environmental and nutritional factors for development of acute lower respiratory 
tract infections.  
 
Zinc deficiency has been shown as a risk factor for acute lower respiratory 
tract infections in recently available studies. In developing countries like India 
dietary zinc deficiency is widespread and is aggravated by acute and chronic 
infections. 
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Role of zinc in acute lower respiratory tract infections: 
Zinc has an important role in the normal hosts defence mechanisms and 
immune system. Zinc deficiency damages epidermal cells and thus breaks the 
integrity of the physical barrier that prevents the entry of pathogens. Damage to 
gastrointestinal and respiratory tract occurs in zinc deficient state. 
In severely zinc deficient children reduction in the size of thymus occurs thus 
affecting cell mediated immunity and T cell function. Mild zinc deficiency also 
depresses cell mediated immunity. It reduces serum thymulin and it is required for 
the biological actions of thymulin(18). 
Zinc ions play an important role in T- lymphocyte generation, proliferation 
and function. Zinc deficiency results in lymphopenia and a reduction in T 
lymphocytes.  There is decrease in the CD4+/CD8+ cells and reduced NK cell 
activity(18). 
In zinc deficiency B lymphocyte development is also affected. Neutrophil 
chemotaxis and function are impaired in zinc deficiency. Monocytes and 
macrophage functions are also impaired.  
Zinc also exhibits anti oxidant and ant inflammatory effects. Antibody 
production is also impaired in zinc deficiency. Worldwide zinc deficiency is 
responsible for 16 % of lower respiratory tract infections, 18% of malaria and 
10% of diarrhoea.(20)   The highest attributable fractions for lower respiratory 
tract infections occur in Southeast Asia. 
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Health benefits of zinc: 
1. Immune system:  
Zinc is a component of  thymic hormone which facilitates the maturation of 
lymphocytes. Due to zinc`s role in maintaining skin and mucus membranes, it is 
important for wound healing. Zinc prevents the replication of rhinovirus which is 
responsible for common cold. 
 
2. Growth and development:  
Zinc affects the growth regulating hormone IGF-1. In zinc deficiency 
this hormone cannot function properly leading to stunted growth in young 
children. 
3. Pregnancy:  
Zinc deficiency can lead to in utero growth retardation, two-fold increase 
in risk of low birth weight and higher risk of pre-term delivery. 
4. Reproductive health: 
Zinc is required for the normal function of prostate gland, to manufacture 
testosterone, and to ensure healthy sperm production since the pituitary glands 
need zinc to release hormones to produce testosterone(14). 
Zinc also inhibits the aromatase enzyme that converts testosterone into 
excess estrogen. The testosterone to estrogen ratio declines with age from a 
high of 50:1 to half or even as low as 10:1. Higher estrogen activity results in 
increased risk of heart disease and obesity.  
Zinc deficiency predisposes the prostate gland to infection (prostatitis) and 
enlargement (prostatic hypertrophy). 
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5. Glycemic control: 
Decrease in zinc decreases the insulin response thereby destabilizing the 
blood sugar. Zinc deficiency also decreases the metabolic rate. 
 
6.  Thyroid:  
In zinc deficiency iodine cannot assist the thyroid gland to produce thyroid 
hormone thereby leading to decreased hormonal output. 
7. Taste and smell:  
Gustin a protein responsible for taste found in saliva needs zinc for normal 
function. Since smell and taste are interconnected, zinc deficiency causes impaired 
taste and smell. 
8. Eye:  
Zinc is needed to convert retinol to retinal allowing for proper night vision. 
Zinc prevents cellular damage to retina and macula. Zinc in the retina decreases 
with age and zinc deficiency predisposes to age related macular degeneration(11). 
9. Brain: 
Zinc is found in the mossy fiber system of hippocampus. These fibres play 
a role in enhancing memory and thinking skills. 
10. Skin: 
Zinc is essential for healthy skin. Zinc stimulates cell division, normal skin 
healing, proper connective tissue formation and transport of vitamin A from liver 
to skin. Zinc compounds are used in the treatment of nappy rash, acne and 
sunburn. 
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Zinc toxicity: 
Excessive exposure to zinc can occur by inhalation, through skin or by 
ingestion. Zinc toxicity can cause lethargy, focal neuronal deficits, metal fume 
fever, nausea, vomiting, epigastric pain, diarrhoea, increased risk of prostate 
cancer, copper deficiency and altered lymphocyte function. 
 
ZINC IN ACUTE LOWER RESPIRATORY INFECTIONS: 
Infant and child zinc supplementation has been extensively studied 
because dietary zinc deficiency is highly prevalent in developing countries. Indian 
children are particularly vulnerable to zinc deficiency because of inadequate 
breast feeding, improper weaning foods, cereal-based diet and frequent diarrhoeal 
illness. 
A recent meta- analysis of randomized efficacy trials conducted in south 
Asia has confirmed that routine oral daily or weekly supplementation of zinc for 
at least three months  
significantly reduces the incidence of childhood acute lower respiratory tract 
infections(19). 
Further this effect of zinc has been found to be more specific for non-
wheezy acute lower respiratory tract infections which is more likely to be due to 
pneumonia than viral bronchiolitis. This effect appears to increase with greater 
severity of disease and was not evident in infants less than six months of age. 
In contrast to the prophylactic effect of zinc, there is no strong evidence of 
any benefit of zinc supplementation in the treatment of acute lower respiratory 
tract infections. 
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Studies on zinc in acute lower respiratory tract infections: 
A study done in well nourished  children in Bangladesh (Shakur M S et al 
2004)  showed that serum zinc was low in children suffering from acute lower 
respiratory tract infections as compared to controls( 90µg/dL versus 176µg/dL). 
(21) 
In another study of  the serum and hair zinc status done in Bangladesh (Shakur 
M S et al 2009) in children with protein energy malnutrition(PEM) associated 
with or without acute lower respiratory tract infections, both serum and hair zinc 
were found significantly low in PEM associated with acute lower respiratory tract 
infections(22). 
Arica S et al( 2011) studied serum zinc levels in children younger than 2 years 
diagnosed with pneumonia. Zinc and iron values in the control group were 
significantly higher compared to the patient group. Mean total protein was also 
significantly higher in control group compared to patient group(23). 
A study regarding the association of serum zinc level with severe pneumonia 
in children of 2- 60 months age  done by Pushpa et al( 2009) showed mean serum 
zinc level was 184µg/dl in the study group compared to 206µg/dl in the control 
group which was statistically significant(24). 
Wahed M A et al( 2008) studied the effects of supplementation of 5 
micronutrients( vitamin A,C,E, folic acid and zinc) in under-5 children on the 
morbidity and duration of hospital stay in pneumonia. The average level of all the 
micronutrients were low in the study group compared to the control group. The 
average duration of hospital stay was 6.75days in study group versus 7.75days in 
control group(25). 
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Javed F et al( 2009) compared serum zinc levels between healthy and 
malnourished children. The mean serum zinc level of healthy children was 
99.97µg/dl compared to 51.2µg/dl in malnourished children(26). 
Coles C L et al(2008) evaluated the effect of zinc prophylaxis on the 
association between nasopharyngeal colonization of streptococcus pneumonia and 
acute lower respiratory tract infections in children aged 1-35 months in Nepal.(27) 
Streptococcus pneumonia carriage increased the risk of acute lower respiratory 
tract infections in the control group but not in the zinc study group. The odds of 
acute lower respiratory tract infections for streptococcus carriers was 30 times 
greater than in the zinc group. 
According to Kumar et al children with severe pneumonia have lower blood 
zinc levels than age, sex and nutritional status matched controls. (28) 
Brooks et al studied effect of zinc on children less than 2 years old with 
pneumonia. Children  with   pneumonia   were divided into 2 groups.  20 mg of 
elemental zinc given to case group  and control group received placebo. In 
children who received zinc there was improvement in the  severity of disease. 
Duration of  hospital stay was shorter in children receiving zinc.(29) 
According to Mahalanabis et al severity of disease was decreased in those 
patients who received zinc. (30) 
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AIM OF THE STUDY 
 
The  aim of  this  study  is   to  
 
 Assess the  serum   level of zinc in acute lower respiratory tract infections  
 
 Correlate with the need for intravenous antibiotics, severity and  recovery 
pattern of acute lower respiratory tract   infections  
 
 Compare with age , sex  and  nutritional status  matched controls 
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MATERIALS AND METHODS 
 
STUDY DESIGN :   
This is a case control study conducted in the Paediatric Department  of  
Government  Royapettah  Hospital attached to Kilpauk Medical  college  during 
the period between March 2012 to  September 2012. 
SAMPLE SIZE : 
 The study population  was chosen from the children coming to the 
paediatric department of Government  Royapettah  Hospital. The sample  size  
included 100 cases of Acute lower respiratory tract infection  and 100  sex, age 
and nutritional status matched children as controls 
INCLUSION CRITERIA : 
          Children aged 6 months to 5 years admitted in the Paediatric Department of 
Government Royapettah hospital with cough with fast breathing and fever were 
included in the study  
A diagnosis of severe acute lower respiratory tract infection was based on 
the presence of  tachypnea, chest retractions and signs of severe disease such as 
high fever, convulsions, extreme lethargy or inability to suck or drink.  
Moderate cases were defined as those with  tachypnnea and chest 
retractions.  
Children presenting with only tachypnnea were diagnosed to have mild 
acute lower respiratory tract infections. 
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Severity of ALRIs 
 
 
 
 
 
To label the child as tachypneic, the WHO guidelines were followed. For 
children  less than 2 months, respiratory rate  60 and above per minute, for 2 to 12 
months, respiratory rate of 50 and per minute and more than 1 year respiratory 
rate of  40 and above  per minute was labelled as tachypnea. The respiratory rate 
was counted for one minute 
100 children age, sex and nutritional status matched  with 100  cases of 
ALRI  wre taken as controls.  Normal siblings or children accompanying sick 
children or children coming for immunization were taken as controls.  
 
EXCLUSION CRITERIA : 
Children  with a clinical diagnosis of childhoodl asthma  based on wheeze, 
history of repeated similar episodes,   positive family history of bronchial asthma   
and  rapid  response  to  bronchodilator therapy were excluded from the study. 
Children  with  diarrhoeal  episodes within the last three months were also 
excluded in the study. 
Children  already on zinc supplementation were also excluded. 
Mild ALRI Tachypnea 
Moderate ALRI Tachypnea with chest retractions 
Severe  ALRI Tachypnea with chest retractions and 
High fever, convulsions, extreme 
lethargy or inability to suck or drink 
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Children satisfying  the inclusion criteria were enrolled in the study. The  
details of study procedure was explained and an informed consent from the 
parents/ Guardian was obtained. The  study  was reviewed and approved by the 
ethical  committee 
Complete physical examination including anthropometry to assess the 
nutritional  status was done for all children included in the study ( cases  and 
controls).   
  Anthropometry is a simple tool and  is the gold standard to assess 
nutritional status. 
 
Weight: 
Weight is an important parameter in assessing the nutritional status of a 
child.  
The  weight of  the child was measured with shoes  removed and minimal 
clothing. The child was not in touch with any other object. The measured weight 
was  corrected to the nearest value of  plus  100 gms. 
 
Height /Length : 
Height of a child was measured in standing posture. Length of the child  
was measured in children less than 2 years in lying posture. The difference 
between height and length is 2cm.   
For children less than  2 years length was measured using an  infantometer.  
Length  measurement required two people. The  child’s shoes were removed & 
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child was placed on a flat surface. One person fixed  the top of child’s head 
against the fixed vertical  board with the eyes of  child eyes looking  upwards. 
 The second  person  pressed the knees together and down firmly in such a 
way that  they touched the horizontal surface.  The mobile foot board was moved 
till it  touches the heels with  the feet kept  at right angle. The height was 
measured and corrected up to the nearest 0.5cm. 
For children more than  two years, the height was measured using a  
stadiometer.  Stadiometer consists of a fixed vertical  board and  a mobile head 
piece.  The child was made  to stand bare foot  with shoes and socks  removed and 
with both feet and knees together. The child was made to stand in such a way that 
the heels, buttocks, shoulders and  occiput touched  the vertical board .  
The head should be kept straight in Frankfurt plane that is the line joining 
the lower margin of the orbit and the upper margin of the external auditory canal 
should be  in a straight line. 
The height was measured by lowering the mobile head piece and placing it  
horizontally so that it touched the top of head. The height was measured up to the 
nearest 0.5cm for accuracy  
 
Mid arm circumference:  
 The  mid arm  circumference was measured using a non stretchable tape 
with the arm hanging by the side of the body. It was measured mid way between 
the acromion and  the olecranon process with the  tape fitting snugly  around the 
arm and not compressing the skin. The measurement was taken to the nearest 0.1 
cm. 
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At the time of enrolment a baseline assessment including a detailed 
physical examination was performed. Chest X-Ray was  taken for all cases of  
acute lower respiratory tract infections. 
At the time of   admission  3 ml of venous blood was collected by 
venipuncture  in zinc free test tubes. The blood samples were then transported to 
lab where serum zinc concentration was measured using colorimetric method. 
METHOD OF SAMPLE COLLECTION:  
Blood sample of 3 ml was collected by venipuncture in zinc free test tubes. 
The serum was then carefully   separated by centrifuging the collected blood 
sample. Care was taken so that the sample was not lysed as 75-85% of zinc are in 
erythrocytes, 12-22% in plasma, and 3% in leukocytes in blood.  Therefore the 
amount of zinc  measured in serum will be artifactually high  if hemolysis occurs. 
If hemolysis occurred, then another sample of blood was collected from  the same 
child. 
 
 
ESTIMATION  OF  SERUM  ZINC  USING COLORIMETRIC 
METHOD(31)  
 
 
PRINCIPLE: 
 
                Zinc in an alkaline medium reacts with Nitro-PAPS to form a purple 
coloured complex. Intensity of the complex formed is directly proportional to the 
amount of zinc present in the sample.  
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  Alkaline Medium 
Zinc  + Nitro-PAPS  -------------------->     Purple Coloured Complex 
 
 
The increase of absorbance is   measured and it is proportional to the 
concentration of total zinc in the sample. 
 
NORMAL REFERENCE VALUES(6) 
Serum : 60-120 µg/dl 
It is recommended that each laboratory establish its own normal range 
representing its patient population. 
 
CONTENTS 25 ml 75 ml 
L1 : Buffer Reagent 20 ml 60 ml 
 
L2 : Color Reagent 5 ml 15 ml 
 
S: Zinc Standard (200 mg/dl) 2 ml 2 ml 
 
 
 
 
 
STORAGE / STABILITY 
Contents are stable at 2-8°C till the expiry mentioned on the labels. 
 
REAGENT PREPARATION 
Reagents are ready to use. 
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Working reagent:  
Pour the contents of 1 bottle of L2 (Enzyme Reagent 2) into 1 bottle of L1 
(Enzyme Reagent (1). This working reagent is stable for at least 2 weeks when 
stored at 2-8°C. 
Alternatively for flexibility as much of working reagent may be made as 
and when desired by mixing together 4 parts of L1 (Enzyme Reagent 1) and 1 part 
of L2 (Enzyme Reagent (2).  
Alternatively 0.8 ml of L1 and 0.2 ml of L2 may also be used instead of 1 
ml of the working reagent directly during the assay. 
 
SAMPLE MATERIAL 
Serum (Free from haemolysis)  
Zinc is reported to be stable in serum for 7 days at 2-8°C. 
 
PROCEDURE 
Wavelength/filter   : 570 nm (Hg 578 nm) / Yellow 
Temperature    : R.T. 
Light path    : 1 cm 
 
  
29 
 
Pipette into clean dry test tubes labelled as Blank (B), Standard (S) and Test (T): 
 
Addition 
Sequence 
B  
(ml) 
S  
(ml)  
 
T  
(ml) 
 
Working Reagent 1.0 1.0 1.0 
 
Distilled Water 0.05 -- -- 
 
Zinc Standard (S) -- 0.05 -- 
 
Sample -- -- 0.05 
 
 
Mix well and incubate at R.T. (25°C) for 5 minutes. 
Measure the absorbance of the sample As and the absorbance of standard 
Ast against reagent blank  within 20 minutes. 
 
 
CALCULATION:    
 
Zinc concentration in the sample was calculated with the following formula.  
 
 
  Zinc concentration(mg/dl)  =    
	


  X 200 
 
 
All the data were collected  and written on a predesigned proforma. The 
variables analyzed were as follows  age, sex , nutritional status which included 
weight for age%,  weight for height% and mid arm circumference, disease pattern, 
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severity, need of antibiotics, need of O2, SpO2, duration of hospital stay and 
serum zinc status. For all children who had zinc deficiency zinc was supplemented  
20 mg daily for 14 days. 
The data were entered in excel and statistical analysis was done  using 
SPSS 11.5 version statistical software. 
 Descriptive analysis was used. Means with standard deviations were 
calculated.  P-values were obtained by applying ANOVA and  Chisquare test to 
analyze the  data. 
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DESCRIPTIVE STATISTICS 
 
100 cases of acute lower respiratory tract infections were studied and 100 
controls matched with age sex and nutritional status were taken into the study. 
Age was matched with in 3 months and for matching nutritional status  weight for 
age was taken. 
As children were age and  sex  matched in  both cases and controls, the 
number of children in each age group and the number of males and females in 
cases and controls  were the same. 
 There were 53 (53%) males   and 47 (47 %) females in each group. The 
mean age group in male  and in female was 2 years. 
 
 
  
 
 
 
 
 
 
Sex distribution of cases and controls 
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DISTRIBUTION ACCORDING TO AGE : 
 
There were 25 children in the age group less than 1 year , 49 children in 1 
to  3 years age group and 26 children in the age group of 3 to 5 years.   
The mean of   age group  of less than 1 year, 1 to 3  years and  3 to 5 years  
in cases were 9 months, 2 years and 3.75  years  respectively.  
The mean of  age group  of less than 1 year , 1 to 3  years and  3 to 5 years  
in controls were 9.5,  2.25 years and 3.75 years respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age distribution  in cases and controls 
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MORBIDITY  PATTERN : 
 
 
  Among the 100 cases of acute lower respiratory tract infections  there were 
16 cases of  bronchiolitis , 51 cases of pneumonia, 12 cases of lobar pneumonia 
and 21 cases with clinical diagnosis of acute lower respiratory tract infections and 
no radiological  abnormality. In this study the majority of the cases were 
pneumonia. 
 The mean age of  bronchiolitis, pneumonia  and lobar pneumonia were 1 
year, 2 ½ 
 
 years and  1 ¾ years respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Morbidity pattern  of cases 
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In  bronchiolitis  there were 11 males and 5 females. In pneumonia there  
were 22 males and 29 females. In  lobar pneumonia there were 6 males  and 6  
females . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mean age in bronchiolitis, pneumonia, lobar pneumonia and cases  
with clinical diagnosis of acute lower respiratory tract infections and no 
radiological abnormality were 1 year , 2 ½ years , 1 ¾ years and 2 ¼ years  
respectively. Bronchiolitis was seen more in the  age group of  less than 1 year. 
Lobar pneumonia was seen in more in the age group of  1 to 3 years and 
pneumonia seen more in the age group  of 3 to 5 years. 
 
Sex   distribution in various disease patterns 
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IAP classification ( weight for age %)
 
Normal 
Grade I PEM 
Grade II PEM 
Grade III PEM 
Grade IV PEM 
 
The distribution of cases according to nutritional status in the various 
disease patterns   is  shown on the following chart. 
malnutrition was graded based on the IAP classification (weight for age (%) o
50th percentile is calculated)
Age distribution in various disease pattern
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According to the study, nutritional status in bronchiolitis was normal. 
Lobar pneumonia was seen more in grade II  and grade III malnutrition. In 
pneumonia the nutritional status of the children in this study was mostly normal or 
grade I PEM. 
 
 
Distribution according to Nutritional Status in various disease patterns 
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The distribution of cases according to the severity in the various disease  
pattern in acute  lower respiratory tract infections is shown in the above  bar 
diagram. 
In this study most cases of bronchiolitis and pneumonia presented as 
moderate acute lower respiratory tract infections while in lobar pneumonia the 
presentation was mostly severe. 
 
 
 
Severity in various disease patterns 
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DISTRIBUTION OF CASES ACCORDING TO THE  SEVERITY 
 
 
 
The above bar diagram shows the distribution of cases according to the 
severity of illness. In our hospital most cases presented as moderate and mild 
acute lower respiratory tract infections. However the difference of presentation for 
mild and moderate was not statistically significant. 
 
 
 
 
 
Distribution according severity  
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The  distribution of cases according to age group and severity is shown in 
the above bar diagram. In this study more number of severe cases were seen in the 
age group of 1 to 3 years that is the toddlers. There was not much of  significant 
difference in the severity in infants and the preschool age group that is 3 to 5 years 
who presented mostly  as moderate and mild acute lower respiratory tract 
infections. The mean age in mild, moderate and severe ALRI was  2 ½ , 2 and 1 ½ 
years respectively. 
The distribution of cases according to sex in mild, moderate and severe 
acute lower respiratory tract infections is shown in the following bar diagram. 
Distribution according to age and severity 
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There was no significant   statistical  difference in male or female predominance 
in the severity of acute lower respiratory tract infections.  
 
 
 
 
 
 
 
 
 
 
 
Distribution according to sex and severity 
Severe 
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ACCORDING TO NUTRITIONAL STATUS 
 The nutritional status in the study population was assessed by the 
measuring the anthropometry and grading the nutritional status by  
IAP classification -  weight for age % 
Waterlows classification – weight  for height %  and  
Mid arm circumference 
    
 The above bar diagram shows the nutritional status of the study population. Most 
of the children fall under grade II PEM followed by grade I PEM.  
 
Nutritional status – IAP classification in cases and controls 
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The male female distribution according to the IAP classification was almost equal. 
 The following bar diagram shows the nutritional status in various age 
groups that is infants, toddlers and preschool children. In this study most of them 
had grade II PEM and majority of them were toddlers. 
 
 
 
 
 
 
 
 
 
Distribution according to age and nutritional status 
Sex Distribution in weight for age% 
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Waterlows classification is based on weight for  height%. There was no 
significant difference in the male female distribution according to the Waterlows 
classification. 
Normal >90% 
Mild wasting 80 to 90% 
Moderate wasting 70-79% 
Severe wasting < 70% 
 
 
 
 
Weight for height% and sex  distribution 
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Age distribution in weight for height % 
 
In our study population most of the children in the age group 1 to 3 years 
had severe  and  moderate wasting. 
 
 
   
Male- female distribution and MAC 
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In  this study the mid arm circumference was also used to assess the  
nutritional status. If mid arm circumference  is more than 13.5cm  it is normal. If 
it is 12.5cm  to 13.5cm then it is borderline. It is wasted if it is less than 12.5cm. 
 The above chart shows the  sex distribution and the grading of nutritional 
status according to the MAC. 
In our study population most of our children fell under the borderline line 
category that is 12.5 to 13.5.  There was no significant difference between the age 
distribution and  MAC grading. 
 
 
 
Out of 100 cases of acute lower respiratory tract infections oral antibiotics was 
given to 58 children and intravenous   antibiotics given to 27 children. 
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For all  children with acute lower respiratory tract infections oxygen saturation 
was checked  with a   pulse oximeter. Out of 100 cases 7 children had SpO2 of less 
than 94%.  In the treatment of  acute lower respiratory tract infections oxygen was 
given to  10%  of children. 
 
                
                    
 
 
 
 
 
Oxygen requirement in ALRI 
                               Need of antibiotics in ALRI 
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Hospital stay for 2 children was more than 14 days. For 63 children hospital stay 
was 7 to 14 days  and for 35 children the duration of hospital stay was less than 7 
days. 
 
 
 
 
 
 
 
 
 
 
 
Duration of hospital stay in ALRI 
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ZINC  DEFICIENCY STATUS : 
 
 The  normal zinc level in serum in  children is 60 to 120 µg/ dl.(6) If the 
serum zinc level  is less than 60 µg/ dl then it was taken as zinc  deficiency status.  
In this  study out of 100 cases  of acute lower respiratory tract infections, 
76% had zinc deficiency status and 24% had normal serum zinc status. In  100 
controls 19%  had zinc deficiency while  81% had normal zinc levels. 
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 ZINC   DEFICIENCY
 
Out of 53 male  children with 
children had zinc deficiency 
53  children taken as controls, 
children with acute lower respiratory tract infections
deficiency and 12 children had  normal zinc status. Out of 47 female children 
taken as controls, 13 were deficient in zinc while 40  had normal zinc levels
. 
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 Zinc deficiency  status  in male  and female 
49 
   STATUS   AND   SEX DISTRIBUTION:
acute lower respiratory tract infections
and 12 children had normal zinc levels.  Similarly in
13 children were deficient in zinc.
 ,35 children had  zinc 
Case Control 
< 60 > 60 < 60 > 60 
41 12 13 40 
 
35 12 6 41 
 
 
male > 60 female < 60 female > 60
12
35
12
40
6
41
– cases and controls
 
, 41 
 
 In 47 female  
. 
 
cases
controls
 
 
  
 Zinc deficiency was 77.35%  
male controls. Similarly zinc deficiency in female cases was 74.4% and in female 
controls 12.70%. 
 
ZINC DEFICIENCY IN DIFFERENT AGE GROU
The deficiency status of zinc levels in different age groups  is  given in the 
table below. In infants with 
children, 16 cases had zinc deficiency and 9  had  normal  zinc levels.  In infants 
taken as controls 6 had deficient  levels  and 19 had normal levels.
In the toddler age group ( 1 to 3 years ) out of 49 cases
in zinc and 10 had normal zinc  level
deficiency and  42 had normal  z
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In the  preschool age group ( 3 to 5years) out of 26 cases
deficient and 5 had normal zi
zinc and 20 had normal zinc 
 
 
 
SERUM ZINC  DEFICIENCY STATUS AND NUTRITIONAL STATUS
The following chart shows  the number of cases with zinc deficiency based 
on nutritional  status( weight for age %)
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The following chart shows  the number of controls  with zinc deficiency 
based on nutritional  status (weight for age %)
 
Zinc deficiency status and nutritional status Wt/age%
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Zinc deficiency and nutritional status 
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   In grade III PEM 
while 66.6 % Grade III
cases had zinc deficiency and 13.86% of controls had zinc deficiency In grade I 
PEM 80.6% of cases had zinc deficiency and 19.3% of controls had  zinc 
deficiency. In normal children with weight for age % 81 
zinc deficiency and 29.5% of controls had  zinc
more than 90%, 38.40% of cases had zinc deficiency and  23 % of controls had 
zinc deficiency. 
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SERUM ZINC  DEFICIENCY STATUS IN  VARIOUS  DISEASE 
PATTERNS 
             The status of zinc deficiency in the various disease patterns of acute lower 
respiratory tract infections is given in the table below.  According to the study 
zinc  deficiency  status was   seen  more  in lobar pneumonia,  pneumonia and in  
children   with  clinical  diagnosis  of  acute lower respiratory tract infections but 
no radiological  abnormality  than  in  bronchiolitis. 
 
 
Zinc deficiency status and various disease patterns 
  
                In bronchiolitis 33.3 % of children
80.4 % of children had zinc 
abnormality 90.4  %  had zinc deficiency.
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 had  zinc deficiency. In  pneumonia 
deficiency  and in ALRI with  no  radiological  
 
Diagnosis 
Case 
< 60 > 60
Bronchiolitis 4 12 
Pneumonia 41 10 
Lobar pneumonia 12 0 
Others 19 2 
Pneumonia Lobar 
pneumonia
Others
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0
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Zinc deficiency   in various disease patterns
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SERUM  ZINC DEFICIENCY STATUS AND SEVERITY OF ILLNESS   
The number of children with zinc deficiency in mild, moderate and severe 
acute lower respiratory tract infections is given in the table below. According to 
this study more number of  children in severe acute lower respiratory tract 
infections were deficient in zinc  than the children with moderate and mild acute 
lower respiratory tract infections. 
 
Severity < 60 > 60 
Mild 23 9 
Moderate 31 13 
Severe 22 2 
 
Zinc deficiency and severity in ALRI 
   In mild ALRI 71.8 %  had zinc 
zinc deficiency and in severe ALRI 91.6% had zinc  deficiency.
 
SERUM ZINC DEFICIENCY STATUS AND ANTIBIOTICS
In this study zinc deficiency wa
respiratory tract infections w
 Zinc deficiency was seen in more  number of children with 
respiratory tract infections 
needed oral  antibiotics.
In cases of ALRI who were not given any antibiotic
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Antibiotic < 60 > 60 
Not given 4 11 
IV  50 8 
Oral 22 5 
 
No
Oral
IV
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Zinc  deficiency status
respiratory tract infections who needed a prolonged hospital stay
whose hospital stay was < 7 days had zinc deficiency. In ca
to 14 days, 82.5 % had zinc deficiency and in children with hospital stay >14 days zinc  
deficiency was seen in 100 % of cases.
 
 
Zinc deficiency and duration of hospital stay
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SERUM ZINC STATUS  
  The  mean serum zinc levels in cases was 60.18  µg/dL and in 
controls  was          80.42 µg/dL .  The p value was  0.001 which is significant.  
The association of serum zinc level in both groups is detailed in the table below. 
 
 Mean Serum 
Zinc 
SD P-Value Sig 
Case 60.18 14.8           
0.001 
                 
S Control 80.42 18.2 
 
 
Zinc deficiency and duration of hospital stay 
  
 
Serum Zinc and Sex Distribution:
 The association between serum zinc  and sex distribution is giv
table below. There were
cases and female cases were
serum zinc in  male  controls and fem
respectively.  
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 53 males and 47 females. The mean serum zinc of
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Serum zinc and age distributi
 The mean serum zinc levels in  the various age groups are given in the 
table below. The mean zinc level in cases in age group less than 1 year ,  1 
years  and 3  to 5 years we
respectively. 
Similarly the mean zinc levels in controls  for 
year ,  1  to 3 years  and 3  to 5 years we
respectively. 
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re 65.2 µg/dL, 57.8 µg/dL  and 59.8 
the age group less than 1 
re 85.4 µg/dL, 79.2 µg/dL  and 77.9 
female
59.3
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 Male Female  P-Value Sig 
 
61.0 59.3 0.6 NS 
 
77.8 83.4 0.6 NS 
Mean serum zinc in cases and controls 
 
 to 3 
µg/dL  
µg/dL  
cases
controls
64 
 
 
 
 
Age < 1 1 - 3 3 - 5  
Case 65.2 57.8 59.8 NS 
Control 85.4 79.2 77.9 NS 
 
 
SERUM  ZINC AND NUTRITIONAL  STATUS 
                            The difference in the mean zinc  level in cases  and controls 
were significant in grade I, grade II, grade III  and 81 to 90% weight for age %. In 
weight for age %  more than 90 %, the difference between cases and controls was 
not statistically significant.   
 Also the difference  in zinc levels  between  81 to 90 %, grade I, 
grade II and Grade III malnutrition was not significant when compared to the 
Mean serum zinc level  in cases and controls in different age groups 
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difference between weight for age %  more  than  90 % and the other  grades of  
malnutrition. 
 The association between zinc levels of weight for age % in  
cases and controls is given in the table below. 
Wt for 
age % No Case Control 
P-
Value Sig 
< 60 3 50.0 72.7 0.004 S 
60 - 69 36 56.3 78.7 0.000 S 
70 - 79 31 58.0 80.4 0.000 S 
80 - 89 17 60.9 80.8 0.002 S 
> 90 13 77.5 86.6 0.344 NS 
 
 
 
 
 
 
Mean serum zinc levels in cases and controls according to weight /age% 
 The association between the serum zinc level and weight for h
shown in  the  chart below.
severe wasting  was not significant when compared to  the difference between 
normal weight for height %  and the other  grades of wasting.
     
In weight for height % 
In weight for height % 70 
controls.  In  weight for height
in  controls.  In weight for height %  >90% 
in controls. 
 
SERUM ZINC STATUS AND  MID ARM CIRCUMFERENCE
 The association between zinc status and mid arm circum
in the chart below. The 
normal mid arm  circumference and  mid arm  circumference indicating  
0
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< 70 %
54.23
68.5
Mean serum zinc in weight/height %
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 The difference  in zinc levels  in mild
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 malnutrition. But the differenc
statistically significant.
In MAC < 12.5 cm 
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76.7. In MAC > 13.5  cm  
SERUM ZINC AND DISEASE PATTERN:
 The association between serum zinc  level and disease pattern is detailed in 
the table below. In br
normal zinc status.   
The mean serum zinc levels of bronchopneumonia, 
acute lower respiratory tract infections with only clinical  
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lower respiratory tract infections were 58.1 µg/dL, 50 µg/dL and 57.3 µg/dL  
respectively. 
  However  the  difference in zinc level  between bronchiolitis and the 
other forms of  acute lower respiratory tract infections  is statistically significant 
with  p value of 0.001. 
 
 
 
 
 
 
 
 
 
 
Diagnosis N Mean of Serum Zinc 
P-
Value Sig 
Bronchiolitis 16 78.4 
0.001 S Pneumonia 51 58.1 Lobar pneumonia 12 50.0 
Others 21 57.3 
Mean serum zinc level in various disease patterns 
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SERUM ZINC STATUS AND SEVERITY: 
 The   association between zinc status  and severity of acute lower 
respiratory tract infections is given  in the table below . The  mean serum zinc  of 
mild moderate and  severe acute lower respiratory tract infections were 66.56 
µg/dL , 58.59 µg/dL and 54.58 µg/dL respectively.  
Serum zinc status between mild acute lower respiratory tract infections and 
moderate or severe acute lower respiratory tract infections was statistically  
significant as the  p  value was 0.007. But the difference between moderate and 
severe ALRI was not statistically significant. 
 
Severity No 
Mean 
Serum 
Zinc 
P-
Value Sig 
Mild 32 66.56 
0.007 S Moderate 44 58.59 
Severe 24 54.58 
Total 100 60.18   
 
 
66.56
58.59
54.58
0
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30
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70
Mild Moderate Severe
Mean serum  zinc level according to severity of ALRI 
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SERUM ZINC STATUS AND ANTIBIOTICS: 
The mean zinc  level in children who  needed oral  and IV antibiotics were 
60.78 µg/dL  and 55.02 µg/dL  respectively. The mean zinc level in children who 
did not need antibiotics was 79.07 µg/dL  which fell in the  normal range of serum 
zinc level.  
Therefore there is a significant association between serum zinc status and 
the need for antibiotics. The p value  is  0.0001 which is statistically significant. 
 
Antibiotic N Mean of Serum Zinc 
P-
Value Sig 
Not given 15 79.07 
0.001 S IV  58 55.02 
Oral 27 60.78 
Total 100 60.18   
Mean serum  zinc level according to severity of ALRI in male and female 
  
SERUM ZINC STATUS AND Sp
 The association betw
table below. There was not much difference in
with SpO2 less than and  more than
The mean zinc level of children with Sp
94 % were 60.7 µg/dL and 60 
The mean serum zinc of children who need
oxygen  were 62.6 µg/dL and  59.91 
therefore  not significant.
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 the zinc  level between the children  
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O2 less than 94%and  more than
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SpO2 No Mean of Serum Zinc 
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Total 100 
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SERUM ZINC STATUS AND DURATION OF HOSPITAL STAY: 
The association between the serum zinc level and the  duration of hospital 
stay is given in the table below.  The mean zinc level of children with hospital 
stay less than 7 days, 7 to 14 days and more than 14 days were 67.31 µg/dL, 56.57 
µg/dL and 49 µg/dL respectively.  The p  value is 0.0001 and therefore significant. 
 The  mean zinc  level  of the children with hospital stay of more than 7 
days  fell in the deficiency  range. 
 
 
 
 
 
 
 
 
Oxygen N Mean of Serum Zinc P-Value Sig 
Yes 10 62.6 0.592 NS No 90 59.91 
Total 100 60.18   
 0
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Total 
Mean  serum zinc and duration of hospital stay
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N Mean of Serum Zinc P-Value Sig
 
35 67.31 
0.001 S63 56.57 
2 49 
100 60.18   
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OBSERVATION 
The following observations were  made in this  case control study done  in 
Government Royapettah Hospital. The total number of study population was 200 
which included 100 cases and 100 controls.  
Study  population included 100 children with acute lower respiratory tract 
infections  in the age group 6 months to 5 years and  100 sex, age and nutritional  
status matched children were taken as controls. 
Among them 53 were male children and 47 were female children. The 
mean age group in male  and in female was 2 years. There were 25 children in the 
age group less than 1 year , 49 children in 1 to  3 years age group and 26 children 
in the age group of 3 to 5 years.   
Among the 100 cases of acute lower respiratory tract infections  16 cases 
were bronchiolitis, 51 cases were bronchopneumonia, 12 cases were lobar 
pneumonia .Among the 100 cases  majority of the children  were cases of  
bronchopneumonia.  
There were 32 cases of mild acute lower respiratory tract infections, 44 
cases of  moderate acute lower respiratory tract infections and 24  cases of  severe 
acute lower respiratory tract infections.  
Among the 100 cases of acute lower respiratory tract infections most  
children presented as moderate acute lower respiratory tract infections. 
 Most of the children were in grade II  PEM  followed  by   grade I PEM    
according   to   IAP classification. 30 children had normal nourishment, while 31 
fell under grade I PEM, 36 fell  under grade II PEM and 3 fell under grade III  
PEM. 
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 Based on  Waterlows classification most of the children were in the 80  to  
89% group. 
 Based on the mid arm  circumference  most of our children fell in  the 
borderline line category that is 12.5 to 13.5.   
          In the treatment of acute lower respiratory tract infections out of 100 cases 
of acute lower respiratory tract infections 58 children needed  oral antibiotics and 
27 children needed  intravenous   antibiotics. 10% of children needed oxygen.   
In this  study out of 100 cases  of acute lower respiratory tract infections, 
76% had zinc deficiency status and 24% had normal serum zinc status. In  100 
controls 19%  had zinc deficiency while  81% had normal zinc levels. 
Zinc deficiency was 77.35%  in male children with ALRI  and 24.5% in 
male controls. Similarly zinc deficiency in female cases was 74.4% and in female 
controls 12.70% 
In grade III PEM children with ALRI zinc deficiency was seen in 100% 
while 66.6 % Grade III controls had  zinc deficiency. In grade II PEM  86.2% of 
cases had zinc deficiency and 13.86% of controls had zinc deficiency In grade I 
PEM 80.6% of cases had zinc deficiency and 19.3% of controls had  zinc 
deficiency. In normal children with weight for age % 81 – 90%, 70.5 % cases had 
zinc deficiency and 29.5% of controls had  zinc deficiency. In Weight for age  % 
more than 90%, 38.40% of cases had zinc deficiency and  23 % of controls had 
zinc deficiency. 
In bronchiolitis 33.3 % of children had  zinc deficiency. In  pneumonia 
80.4 % of children had zinc deficiency  and in ALRI with  no  radiological  
abnormality 90.4  %  had zinc deficiency. 
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In mild ALRI 71.8 %  had zinc deficiency. In moderate ALRI 70.4 % had 
zinc deficiency and in severe ALRI 91.6% had zinc  deficiency. 
In cases of ALRI who were not given any antibiotic 26.6% had zinc 
deficiency. In children  who received  oral antibiotics zinc was deficient in 81.4% 
and in children who received IV antibiotics 86.2 % had zinc deficiency. 
48.8 % of cases whose hospital stay was < 7 days had zinc deficiency. In 
cases whose hospital stay was 7 to 14 days  82.5 % had zinc deficiency and in 
children with hospital stay >14 days zinc  deficiency was seen in 100 % of cases. 
            On analysing the mean serum zinc, the mean  serum zinc level  in  cases of 
acute lower respiratory tract infections was  lesser than the mean serum zinc  level 
in controls and   the  difference was   significant   with      p  value of 0.001. 
 There was no statistical difference in mean serum zinc level between male 
and female and among the different age groups that is less than 1 year, 1 to 3 years 
and 3 to 5 years. 
The difference in mean serum  zinc level  between cases and controls in 
grade I, grade II , grade III PEM and 81 to 90 weight for age % was significant 
where as the difference between cases and controls in weight for age %   more  
than 90 was  not significant. 
The mean serum zinc level  showed a zinc deficiency status  in the severe 
wasting according to Waterlows classification ( weight for height %) . The  mean 
zinc  level  was  highest in normal weight for height %. 
Based on the mid arm circumference the mean serum  zinc  level was 
within the normal limit in normal  nutrition status and deficient in borderline 
malnutrition and wasting. 
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The mean serum  zinc was highest in the children with bronchiolitis and 
lowest in children with  lobar pneumonia. 
The mean serum zinc level  was inversely  proportional to the severity of  
acute lower respiratory tract infections, the  more the severity the lesser the zinc 
level. 
The mean serum zinc level was lowest in the cases who  needed 
intravenous antibiotics. No difference in zinc levels was seen in children who  
needed  oxygen  and who did not need  oxygen.  
Mean serum zinc level  was decreased in cases with   prolonged hospital  
stay.  The mean zinc level fell in  the normal zinc status in children with hospital 
stay  of less than 7 days.  Also  when comparing cases and controls more cases 
had zinc deficiency. In bronchiolitis  more number of children had a normal  zinc 
level. In  pneumonia and lobar pneumonia  more number of children  had a zinc 
deficient state.  
Also when comparing to mild and  moderate acute lower respiratory tract 
infections more number of  children had a zinc deficient status in severe acute 
lower respiratory tract infections.  
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DISCUSSION 
Acute lower respiratory tract infections is a  major cause  of mortality and 
morbidity in children less than 5 years.  Therefore it is necessary to take  steps to 
prevent and  decrease the severity of respiratory tract infections.  
There are many risk factors for acute lower respiratory tract infections. 
Some of the risk factors include  low education, low socioeconomic status, 
environmental  factors,  poor housing, poor  health care, inadequate  vaccination,  
malnutrition, micronutrient deficiency and demographic factors ( age  and gender) 
Among the micronutrients zinc has been considered to have a role in acute 
lower respiratory tract infections.  Either it has a direct role on the respiratory tract 
or it has a role in the immune system  of  the body.  It has also got an anti oxidant 
effect. This may help in reducing the inflammation of the respiratory tract and 
there by aids in healing and quickens recovery from  illnesses. 
Also Zinc deficiency has been considered as a risk  factor  for mortality 
and Disability  Adjusted Life Year  (DALY) according to WHO. According to 
WHO  zinc deficiency contributes to  0.7 % of deaths and 1% of Disability 
Adjusted Life Year(DALY).(33) 
Zinc deficiency has been found to be prevalent in developing countries  
either due to the poor intake of zinc rich food  or due  to  the present of phytate  in 
food substances which decrease the absorption of zinc.  Also the lesser zinc 
content in soil  may be  one of the reasons for the decreased amount of zinc in 
food. 
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Therefore it may be necessary  to supplement zinc to prevent and to 
decrease the severity of acute lower respiratory tract infections.  
There are many  studies  showing zinc supplementation in  decreasing the 
number of episodes  of acute lower respiratory tract infections. In  some studies  
zinc deficiency or a low zinc status is  seen in acute lower respiratory tract 
infections or pneumonia. 
 In this study 53 were male and 47 were female. There were 16 % of 
bronchiolitis , 57 %  of pneumonia and 12% of lobar pneumonia.  32%  had  mild 
ALRI, 44% had moderate ALRI and 24% had severe ARLI. 
In this study serum  zinc level  was low in children with acute lower 
respiratory tract infections  when compared to controls who  were matched with 
age,  sex and nutritional status.  
The  mean serum zinc levels in this study in cases was 60.18  µg/dL +14.8 
µg/dL with CI of  45.38  and  74.98  and in controls  was    80.42 µg/dL + 18.2 
with CI  of 62.22 and 98.62. with p value of 0.001. 
This can be compared with a study in Bangladesh conducted by Shakur M 
S et al which showed  mean serum zinc of   85  + 47 (58-152)  in cases of acute 
lower respiratory tract infections when compared to mean serum zinc of 121 
µg/dL + 48 (68-175) in controls 
The mean serum  zinc was highest in children with bronchiolitis and 
lowest in children with  lobar pneumonia. 
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The mean serum zinc level  was inversely  proportional to the severity of  
acute lower respiratory tract infections, the  more the severity the lesser the zinc 
level. 
The mean serum zinc level was lowest in the cases who  needed 
intravenous antibiotics. No difference in zinc levels was seen in children who  
needed  oxygen  and who did not need  oxygen.  
Mean serum zinc level  was decreased in cases with   prolonged hospital  
stay.  The mean zinc level fell in  the normal zinc status in children with hospital 
stay  of less than 7 days.   
Zinc deficiency   was seen in 76 % of cases and  19 % of controls. In 
bronchiolitis 33.3 % of children had  zinc deficiency. In  pneumonia 80.4 % of 
children had zinc deficiency  and in ALRI with  no  radiological  abnormality 90.4  
%  had zinc deficiency. 
In mild ALRI 71.8 %  had zinc deficiency. In moderate ALRI 70.4 % had 
zinc deficiency and in severe ALRI 91.6% had zinc  deficiency. In cases of ALRI 
who were not given any antibiotic 26.6% had zinc deficiency. In children  who 
received  oral antibiotic zinc was deficient in 81.4% and in children who received 
IV antibiotics 86.2 % had zinc deficiency. 
48.8 % of cases whose hospital stay was < 7 days had zinc deficiency. In 
cases whose hospital stay was 7 to 14 days  82.5 % had zinc deficiency and in 
children with hospital stay >14 days zinc  deficiency seen in 100 % of cases. 
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CONCLUSION 
In this study out of 100  cases,  53 were  male and 47 female. 16 % of 
cases were bronchiolitis ,  51% cases pneumonia and 12 cases were lobar 
pneumonia.32%  had  mild ALRI, 44% had moderate ALRI and 24% had severe 
ARLI. 
Zinc was deficient in 76% of cases and 19% of controls.  Zinc  was 
deficient in 33.33% of children with bronchiolitis and 80.4% of pneumonia  and 
100 % of lobar pneumonia. Zinc deficiency seen  in more number (91.6%) of 
severe ALRI 
  Zinc deficiency was seen in 86.2 %  of cases who  needed IV antibiotics 
and 81.40% of children who  needed oral antibiotics . In cases who did not need 
any antibiotics 26.6% were deficient in  zinc. 
Also children with  hospital stay  of  >14 days  were 100% deficient and   
82.5% of  children with hospital stay 7 to  14 days had zinc deficiency and 48.8% 
of cases with hospital stay < 7 days had zinc deficiency. 
Serum zinc level  was deficient in children with acute lower respiratory 
tract infections when  compared to  children taken as controls.  Low serum zinc 
was seen in malnutrition. But in children with PEM and acute lower respiratory 
tract infections serum zinc was still more lower.  
Serum zinc level was also related to the severity of acute lower respiratory 
tract infections and the  duration of hospital stay. Serum zinc was low in severe 
acute lower respiratory tract infections when compared to mild and moderate 
acute lower respiratory tract infections . Also the serum zinc level  was deficient 
in children who need a prolonged hospital  stay. 
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Also there are many studies showing zinc supplementation as a preventive 
measure of acute lower respiratory tract infections and also  as a measure in 
decreasing the  severity of acute lower respiratory tract infections.  
 
Therefore measures should be taken to prevent the zinc deficiency status  
by   
• Promotion of  breast  feeding 
• Proper introduction of complementary feeds 
• Improving  the dietary habits like improving the increase in animal   
protein and decreased intake of phytate containing food and 
• Zinc supplementation if  necessary. 
 
 There by we can decrease the incidence and severity of acute lower 
respiratory tract infections and thereby reduce the under five mortality. 
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Serum Zinc levels in ALRI 
 
Name :   Age : Sex :  IP.NO.: 
Address:  
Diagnosis :          
Wt :    Ht :            MAC: 
Severity :        
Cough: ______days     Dyspnea: ________ days  
Fever : _________ days    Others : 
RS:      SpO2: HR:   RR: 
X – Ray : 
O2 : yes/ no 
Antibiotics : yes/ no If yes : oral / IV  - __________  
Other treatment:  
Duration of hospital stay: 
 
SERUM ZINC : 
  
SNO age sex DIAGNOSIS  severity serum zinc level  wt(kg)        ht(cm) MAC(cm) SPO2 O2 Antibiotics stay(days) 
1 7M M Bronchiolitis Mild 118 7 68 14.2 > 94%  no nil <7 days  
2 7M M Bronchiolitis Moderate 78 7.3 68 14.1 > 94% no nil <7 days 
3 6M M Bronchiolitis Mild 121 6.3 66 14.3 > 94% no nil <7 days 
4 8M M pneumonia Moderate 52 6.5 68 13.5 > 94% no IV  7 - 14 days 
5 8M M Bronchiolitis Severe 90 7.7 68 13.4 > 94% Yes nil 7 - 14 days 
6 9M M pneumonia Moderate 51 6 68 12.4 > 94% no IV  7 - 14 days 
7 11M M Bronchiolitis Severe 58 8.2 70 13.6 <94% yes nil 7 - 14 days 
8 9M M Others Mild 53 7 69 13.6 > 94% no ORAL <7 days 
9 10M M pneumonia Mild 55 7 70 13 > 94% no ORAL <7 days 
10 10M M pneumonia Moderate 54 6 69.5 12.5 > 94% no IV  7 - 14 days 
11 11M M Others Mild 56 7.5 71 12.6 > 94% no ORAL <7 days 
12 11M M Consolidation Severe 45 5.8 69.5 12.5 > 94% no IV  >14 days 
13 9M M pneumonia Severe 52 5.7 68 12.5 > 94% no IV  7 - 14 days 
14 1 3/4 M Bronchiolitis Mild 108 10 82.5 13.6 > 94% no nil <7 days 
15 2 3/4 M Consolidation Severe 52 8 90 13 > 94% no IV 7 - 14 days 
16 2  1/2 M Others Mild 54 9.5 89 13 > 94% no ORAL <7 days 
17 2  1/4 M pneumonia Mild 99 8 84 13.2 > 94% no ORAL <7 days 
18 1 1/4 M Consolidation Severe 44 7.5 76 13.2 <94% yes IV 7 - 14 days 
19 1 1/4 M Bronchiolitis Severe 56 7.5 76.5 13.1 <94% Yes nil 7 - 14 days 
20 2 M Others Mild 52 8 87 12.6 > 94% no ORAL <7 days 
21 1 1/2 M Bronchiolitis Moderate 74 8.5 81 12.5 > 94% no nil <7 days 
22 2 1/2 M pneumonia Moderate 53 8 88 12.7 > 94% no IV 7 - 14 days 
23 2 1/2 M Others Mild 49 11 90 13.6 > 94% no ORAL <7 days 
24 2  3/4        M pneumonia Moderate 57 8.5 91 13 > 94% no IV 7 - 14 days 
  
25 1 1/2 M Bronchiolitis Moderate 72 9.5 80 13.2 > 94% no nil 7 - 14 days 
26 2 1/2 M Consolidation Severe 54 8.5 88 12.3 > 94% no IV 7 - 14 days 
27 2  3/4 M Others Mild 54 11 93 14 > 94% no ORAL <7 days 
28 2 1/2 M pneumonia Moderate 49 7.5 84 12.6 > 94% no IV 7 - 14 days 
29 2 M Others Mild 53 10 86 13.6 > 94% no ORAL <7 days 
30 1 1/4 M Bronchiolitis Moderate 64 9 77 13.5 > 94% no nil <7 days 
31 1 1/2 M Bronchiolitis Severe 53 9 80 14 <94% yes nil 7 - 14 days 
32 2 M Others Moderate 50 8 85 13 > 94% no IV 7 - 14 days 
33 1 3/4 M Consolidation Severe 55 7.5 80 13.4 > 94% no IV 7 - 14 days 
34 2 3/4 M Others Mild 56 11 93 13.6 > 94% no ORAL <7 days 
35 2 M pneumonia Moderate 52 8 84 12.5 > 94% no IV 7 - 14 days 
36 1.5 M Consolidation Severe 44 7 79 12.4 > 94% no IV 7 - 14 days 
37 2.5 M Others Mild 57 8 88 12.7 > 94% no ORAL <7 days 
38 3 M pneumonia Moderate 51 10 89 13 > 94% no IV 7 - 14 days 
39 1 M pneumonia Severe 52 8 72 13 > 94% no IV 7 - 14 days 
40 3 M Others Mild 56 10 88 13.3 > 94% no ORAL <7 days 
41 3 M pneumonia Moderate 53 9 88 12.7 > 94% no IV 7 - 14 days 
42 3 1/2 M pneumonia Moderate 56 10 90 13.1 > 94% no IV 7 - 14 days 
43 4 M Others Mild 58 13 99 13.6 > 94% no ORAL <7 days 
44 4 M pneumonia Mild 53 11 98 13.1 > 94% no IV 7 - 14 days 
45 4 1/2 M Others Mild 55 13 100 13.7 > 94% no ORAL <7 days 
46 4 1/2 M pneumonia Mild 89 11 99 12.5 > 94% no IV 7 - 14 days 
47 3    M pneumonia Moderate 54 10 88 13.2 > 94% no IV 7 - 14 days 
48 3    M pneumonia Severe 45 10 88 13.3 > 94% no IV 7 - 14 days 
49 3 1/2 M Others Mild 89 11 89 13.4 > 94% no ORAL <7 days 
  
50 3 3/4 M pneumonia Moderate 55 9 90 12.6 > 94% no IV 7 - 14 days 
51 4    M pneumonia Moderate 68 11 94 13.1 > 94% no IV 7 - 14 days 
52 4    M pneumonia Moderate 51 9.5 94 12.6 > 94% no IV 7 - 14 days 
53 4 1/2 M pneumonia Moderate 54 13.5 103 13.6 > 94% no IV 7 - 14 days 
54 10M F pneumonia Moderate 72 7 69 13.7 > 94% no IV 7 - 14 days 
55 11M F Consolidation Severe 54 7 70 12.4 > 94% no IV 7 - 14 days 
56 11M F Bronchiolitis Severe 84 7 68.5 14 <94% yes nil 7 - 14 days 
57 10M F Bronchiolitis Moderate 68 7.5 69 14 > 94% no IV 7 - 14 days 
58 10M F Others Moderate 56 6.5 67 13.2 > 94% no IV 7 - 14 days 
59 9M F pneumonia Severe 54 6 67 13.1 > 94% no IV 7 - 14 days 
60 9M F pneumonia Moderate 52 6 66 13.2 > 94% no IV 7 - 14 days 
61 8M F pneumonia Moderate 69 6 66 13 > 94% no IV 7 - 14 days 
62 8M F pneumonia Mild 53 7.5 66 13.8 > 94% no ORAL <7 days 
63 7M F pneumonia Moderate 72 5.4 65 12.9 > 94% no IV 7 - 14 days 
64 7M F Others Mild 56 6.5 65 13.7 > 94% no ORAL <7 days 
65 6M F Others Mild 57 6 64 13.9 > 94% no ORAL <7 days 
66 2 F pneumonia Moderate 78 7.5 80 12.6 <94% yes IV 7 - 14 days 
67 2 1/2 F pneumonia Mild 57 9.5 86 13.6 > 94% no ORAL <7 days 
68 2 3/4 F Others Mild 56 11 87 14 > 94% no ORAL <7 days 
69 2  1/4 F pneumonia Moderate 54 7.5 86 12.7 > 94% no IV 7 - 14 days 
70 2 1/2 F Consolidation Severe 53 7 85 12.5 > 94% yes IV >14days 
71 2 3/4 F pneumonia Moderate 52 8 87 12.6 > 94% no IV 7 - 14 days 
72 2 3/4 F Others Mild 54 10.5 88 13.5 > 94% no ORAL <7 days 
73 2    F Consolidation Severe 39 7 80 12.5 > 94% no IV 7 - 14 days 
74 1 3/4 F Consolidation Severe 56 8 79 12.4 > 94% no IV 7 - 14 days 
  
75 1 1/2 F Others Moderate 54 6.5 77 12.2 > 94% no IV 7 - 14 days 
76 1 1/2 F Bronchiolitis Moderate 74 8.5 78 13.6 > 94% no nil <7 days 
77 1 1/4 F Bronchiolitis Severe 58 8.5 75 13.7 > 94% yes nil 7 - 14 days 
78 1 1/4 F Consolidation Severe 52 7.5 74 13 > 94% yes IV 7 - 14 days 
79 2 1/2 F pneumonia Moderate 54 8 84 12.5 > 94% no IV 7 - 14 days 
80 2 3/4 F pneumonia Mild 77 11 88 14 > 94% no ORAL <7 days 
81 2 3/4 F pneumonia Moderate 52 8 86 12.6 > 94% no IV 7 - 14 days 
82 2 1/2 F pneumonia Moderate 53 8 84 13 > 94% no IV 7 - 14 days 
83 2 1/4 F pneumonia Moderate 50 9 82 13 > 94% no IV 7 - 14 days 
84 1 3/4 F Consolidation Severe 52 8 79 12.5 <94% Yes IV 7 - 14 days 
85 2 F pneumonia Moderate 68 7 80 12.6 > 94% no IV 7 - 14 days 
86 1 1/4 F pneumonia Moderate 49 10.5 74 13 > 94% no IV 7 - 14 days 
87 1 1/2 F pneumonia Moderate 48 6.5 77 12.5 > 94% no IV 7 - 14 days 
88 1 1/2 F pneumonia Severe 51 7.5 77 13 > 94% no IV 7 - 14 days 
89 1 F Bronchiolitis Moderate 78 8 72 13.9 > 94% no nil <7 days 
90 3    F pneumonia Moderate 54 10.5 90 13.1 > 94% no IV 7 - 14 days 
91 3    F pneumonia Mild 58 11.5 90 13.6 > 94% no ORAL <7 days 
92 3 1/4 F pneumonia Severe 57 9 90 13.6 > 94% no IV 7 - 14 days 
93 3 1/4 F pneumonia Moderate 58 10 91 13.7 > 94% no IV 7 - 14 days 
94 3 1/2 F pneumonia Mild 59 11 92 13 > 94% no ORAL <7 days 
95 4    F pneumonia Moderate 56 10.5 95 12.3 > 94% no IV 7 - 14 days 
96 4    F pneumonia Moderate 54 12 95.5 13.1 > 94% no IV 7 - 14 days 
97 4 1/2 F pneumonia Moderate 55 12.5 98 13.2 > 94% no IV 7 - 14 days 
98 4 3/4 F Others Mild 78 11 99 12.4 > 94% no ORAL <7 days 
99 5    F pneumonia Mild 89 11 102 13.2 > 94% no ORAL <7 days 
  
100 5    F pneumonia Mild 51 12 101 12.6 > 94% no ORAL <7 days 
                          
                          
                          
                          
                          
                          
          CONTROLS               
                          
                          
SNO age sex     Sr. Zinc        ht(cm) MAC(cm)           
1 7M M     112 68.5 14.1           
2 7M M     89 68.5 14.2           
3 6M M     94 66 14.3           
4 8M M     96 68 13.6           
5 8M M     54 68.5 13.4           
6 9M M     94 68.5 12.5           
7 11M M     92 70.5 13.6           
8 9M M     88 69.5 13.7           
9 10M M     52 70 13           
10 10M M     94 69.5 12.6           
11 11M M     51 71.5 12.6           
12 11M M     72 69.5 12.5           
13 9M M     98 68.5 12.6           
14 1 3/4 M     68 82.5 13.6           
  
15 2 3/4 M     78 90 13.1           
16 2  1/2 M     72 89.5 13.1           
17 2  1/4 M     71 84 13.2           
18 1 1/4 M     74 76 13.1           
19 1 1/4 M     78 76.5 13           
20 2 M     88 87.5 12.6           
21 1 1/2 M     88 81.5 12.5           
22 2 1/2 M     98 88 12.6           
23 2 1/2 M     56 90 13.6           
24 2  3/4        M     108 91 13.1           
25 1 1/2 M     49 80 13.2           
26 2 1/2 M     109 88.5 12.2           
27 2  3/4 M     48 93 14           
28        2   1/4 M     74 84.5 12.7           
29 2 M     78 86 13.6           
30 1 1/4 M     72 77.5 13.4           
31 1 1/2 M     54 80 14           
32 2 M     68 85.5 13.4           
33 1 3/4 M     94 80 13.3           
34 2 3/4 M     90 93 13.7           
35 2 M     88 84 12.5           
36 1.5 M     92 79.5 12.3           
37 2.5 M     52 88 12.6           
38 2 M     94 89 13           
39 1 M     92 72.5 13.1           
  
40 3 M     54 88 13.3           
41 3 M     108 87.5 12.8           
42 3 1/2 M     94 90 13.1           
43 4 M     58 98.5 13.6           
44 4 M     74 98 13.2           
45 4 1/2 M     68 100 13.7           
46 4 1/2 M     48 99 12.5           
47 3    M     68 88.5 13.3           
48 3    M     48 88 13.3           
49 3 1/2 M     78 89.5 13.4           
50 3 3/4 M     56 90 12.6           
51 4    M     76 94 13.1           
52 4    M     72 94.5 12.6           
53 4 1/2 M     102 103 13.6           
54 10M F     112 68.5 13.8           
55 11M F     51 70.5 12.3           
56 11M F     104 68.5 14           
57 10M F     110 69 14           
58 10M F     54 67.5 13.4           
59 9M F     112 67 13.1           
60 9M F     98 66.5 13.2           
61 8M F     88 66 13           
62 8M F     108 66 13.8           
63 7M F     71 65.5 12.9           
64 7M F     52 65 13.7           
  
65 6M F     89 64 13.9           
66 2 F     72 80.5 12.6           
67 2 1/2 F     56 86 13.6           
68 2 3/4 F     84 87 14           
69 2  1/4 F     71 86.5 12.7           
70 2 1/2 F     68 85 12.5           
71 2 3/4 F     71 87 12.6           
72 2 3/4 F     78 88.5 13.5           
73 2    F     72 80.5 12.5           
74 1 3/4 F     78 79 12.4           
75 1 1/2 F     88 77.5 12.2           
76 1 1/2 F     102 78 13.6           
77 1 1/4 F     98 75.5 13.7           
78 1 1/4 F     94 74.5 13           
79 2 1/2 F     88 84 12.5           
80 2 3/4 F     112 88 14           
81 2 3/4 F     58 86 12.6           
82 2 1/2 F     88 83.5 13           
83 2 1/4 F     94 82 13           
84 1 3/4 F     74 79.5 12.5           
85 2 F     78 80 12.6           
86 1 1/4 F     54 74 13           
87 1 1/2 F     68 77 12.5           
88 1 1/2 F     78 77 13           
89 1 F     102 72.5 13.9           
  
90 3    F     112 90 13           
91 3    F     108 90.5 13.6           
92 3 1/4 F     78 90 13.7           
93 3 1/4 F     88 91 13.7           
94 3 1/2 F     89 92 13.1           
95 4    F     73 95.5 12.3           
96 4    F     90 95.5 13.1           
97 4 1/2 F     93 98 13.4           
98 4 3/4 F     71 99.5 12.4           
99 5    F     74 101 13.3           
100 5    F     68 102 12.6           
 
  
 
 
